Arch Biopartners Inc.
ACHFF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | -100% | 132.6% | – |
| Gross Profit | $0 | -$0 | $0 | -$0 |
| % Margin | 27.4% | – | 13.3% | 207.8% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -116.1% | – | -78.6% | -0% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -153.3% | – | -352.9% | 305.8% |
| EPS Diluted | -0.004 | -0.01 | -0.006 | -0.018 |
| % Growth | 61.5% | -50% | 64.8% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |